NovoLog FlexPen and Osimertinib Mesylate
Determining the interaction of NovoLog FlexPen and Osimertinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: osimertinib
Brand name: Tagrisso
Synonyms: Osimertinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog FlexPen-Osmitrol
- NovoLog FlexPen-Osmolex ER
- NovoLog FlexPen-OsmoPrep
- NovoLog FlexPen-OsmoPrep Oral
- NovoLog FlexPen-Ospemifene
- NovoLog FlexPen-Osphena
- Osimertinib Mesylate-Novolog Injection
- Osimertinib Mesylate-NovoLog Mix 70/30
- Osimertinib Mesylate-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Osimertinib Mesylate-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Osimertinib Mesylate-NovoLog Mix 70/30 FlexPen
- Osimertinib Mesylate-NovoLog PenFill